FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)

View source ↗

Summary

FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC, resulting in an updated regulatory status for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Cervical Cancer
• Esophageal Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Small Cell Lung Cancer
• Testicular Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

SUPPL AP for CISPLATIN (CISPLATIN)